Mark Pulse

Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?

Steven H. Marshall, Andrea M. Hujer, Laura J. Rojas et al. · Antimicrobial Agents and Chemotherapy · 2017 · 279 citations · Full text

Evaluation of Ceftazidime and NXL104 in Two Murine Models of Infection Due to KPC-Producing <i>Klebsiella pneumoniae</i>

Andrea Endimiani, Kristine M. Hujer, Andrea M. Hujer et al. · Antimicrobial Agents and Chemotherapy · 2010 · 77 citations · Full text

Microbial Pathogens, Klebsiella Pneumoniae, Pharmacotherapy +20

Small Molecule Inhibitors of Staphylococcus aureus RnpA Alter Cellular mRNA Turnover, Exhibit Antimicrobial Activity, and Attenuate Pathogenesis

Patrick D. Olson, Lisa Kuechenmeister, Kelsi L. Anderson et al. · PLoS Pathogens · 2011 · 64 citations · Full text

Small Molecule Inhibitors, Microbial Pathogens, Resistant S. Aureus +20

Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection

Johan A. Kers, Robert E. Sharp, Anthony W. DeFusco et al. · Frontiers in Microbiology · 2018 · 48 citations · Full text

Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes

Robert E. Lee Trout, Allison L. Zulli, Eugen F. Mesaros et al. · Journal of Medicinal Chemistry · 2021 · 41 citations · Full text